Avmapki Fakzynja Co-Pack (avutometinib; defactinib) — Highmark
recurrent low-grade serous ovarian cancer (LGSOC)
Initial criteria
- age ≥ 18 years
- diagnosis of recurrent low-grade serous ovarian cancer (LGSOC)
- disease is KRAS-mutated
- member has received prior systemic therapy